Primary rhabdomyosarcoma of the adult prostate is rare and associated with an aggressive clinical course. Given the limited number of cases reported about the prostate, little is known about the impact of molecular mutations on tumor biology and prognosis in adults. In this article, we present a case of primary embryonal rhabdomyosarcoma of the adult prostate with a complete molecular mutational profile of the tumor.
RaneyBRAndersonJRBarrFGet al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for Intergoup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol. 2001;23:215-220.
2.
BiscegliaMMagroGCarosiICannazzaVDorDB.Primary embryonal rhabdomyosarcoma of the prostate in adults: report of a case and review of the literature. Int J Surg Pathol. 2011;19:831-837.
3.
CiammellaPGaleandroMD’AbbieroNPalmieriTDoniniEIottiC.Prostate embryonal rhabdomyosarcoma in adults: case report and review of literature. Rep Pract Oncol Radiother. 2013;18:310-315.
4.
NascimentoAFFletcherCD.Spindle cell rhabdomyosarcoma in adults. Am J Surg Pathol. 2005;29:1106-1113.
5.
WaringPMNewlandRC.Prostatic embryonal rhabdomyosarcoma in adults. A clinicopathologic review. Cancer. 1992;69:755-762.
NabiGDindaAKDograPN.Primary embryonal rhabdomyosarcoma of prostate in adults: diagnosis and management. Int Urol Nephrol. 2002;34:531-534.
8.
DupreeWBFisherC.Rhabdomyosarcoma of prostate in adult: long-term survival and problem of histologic diagnosis. Urology. 1982;19:80-82.
9.
De BariBStishBBallMWet al. Adult prostatic sarcoma: a contemporary multicenter Rare Cancer Network study. Prostate. 2017;77:1160-1166.
10.
MusserJEAsselMMashniJWSjobergDDRussoP.Adult prostate sarcoma: the Memorial Sloan Kettering experience. Urology. 2014;84:624-628.
11.
SchildhausHULokkaSFennerWKusterJKuhnleIHeinmollerE.Spindle cell embryonal rhabdomyosarcoma of the prostate in an adult patient—case report and review of clinicopathological features. Diagn Pathol. 2016;11:56.
12.
LatzSEllingerJGoltzDet al. Spindle cell rhabdomyosarcoma of the prostate. Int J Urol. 2013;20:935-937.
13.
PrabhakaranPSanjayanRSomanathanTNarayananG.Rhabdomyosarcoma of prostate presenting as bladder outlet obstruction in a young adult. Ecancermedicalscience. 2013;7:360.
14.
AsahinaMSaitoTArakawaAet al. A case of primary spindle cell variant of embryonal rhabdomyosarcoma of the prostate. Int J Clin Exp Pathol. 2014;7:5181-5185.
15.
TreetipsatitJKittikowitWZielenskaMChaipipatMThornerPSShuangshotiS.Mixed embryonal/alveolar rhabdomyosarcoma of the prostate: report of a case with molecular genetic studies and literature review. Pediatr Dev Pathol. 2009;12:383-389.
16.
KadriSLongBCMujacicIet al. Clinical validation of a next-generation sequencing genomic oncology panel via cross-platform benchmarking against established amplicon sequencing assays. J Mol Diagn. 2017;19:43-56.
17.
ParillaMFurtadoLVKadriSSegalJPAnticT.Characterization of molecular alterations in an unusual case of lynch syndrome-associated adrenocortical carcinoma. AJSP Rev Rep. 2017;22:164-170.
18.
WilsonBGRobertsCW.SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer. 2011;11:481-492.
19.
KangSBaderAGVogtPK.Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci U S A. 2005;102:802-807.
20.
DotanZATalRGolijaninDet al. Adult genitourinary sarcoma: the 25-year Memorial Sloan-Kettering experience. J Urol. 2006;176:2033-2039.
21.
WangXLiuLTangHet al. Twenty-five cases of adult sarcoma treated at a high-volume institution from 1989 to 2009. Urology. 2013;82:160-165.
22.
DasguptaRRodebergDA.Update on rhabdomyosarcoma. Semin Pediatr Surg. 2012;21:68-78.
23.
SaltzmanAFCostNG.Current treatment of pediatric bladder and prostate rhabdomyosarcoma. Curr Urol Rep. 2018;19:11.
24.
FletcherCDBridgeJAHogendoornPMertensF.WHO Classification of Tumours of Soft Tissue and Bone. 4th ed.Lyon, France: IARC Press; 2013.
25.
AgaramNPLaQuagliaMPAlaggioRet al. MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification. Mod Pathol. 2019;32:27-36.
26.
NishimuraRTakitaJSato-OtsuboAet al. Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism array. Cancer Sci. 2013;104:856-864.
27.
ScrableHCaveneeWGhavimiFLovellMMorganKSapienzaC.A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc Natl Acad Sci U S A. 1989;86:7480-7484.
28.
AtzoriFTrainaTAIontaMTMassiddaB.Targeting insulin-like growth factor type 1 receptor in cancer therapy. Target Oncol. 2009;4:255-266.
29.
MartinelliSMcDowellHPVigneSDet al. RAS signaling dysregulation in human embryonal rhabdomyosarcoma. Genes Chromosomes Cancer. 2009;48:975-982.
30.
SekiMNishimuraRYoshidaKet al. Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma. Nat Commun. 2015;6:7557.
31.
ShernJFChenLChimieleckiJet al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov. 2014;4:216-231.
